Evidence map›Paper›PMID 42734521›Full record

ArticleJournal of chemical information and modeling2026

Residue Interaction Network Reveals Allosteric Pathways Linking Orthosteric and Intracellular Sites in Class A GPCRs.

Sonja Peter, Georges Chalhoub, Peter J McCormick, Chris De Graaf, Ijen Chen, Giovanni Bottegoni

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sonja PeterNxera Pharma U.K., CambridgeCB21 6DG, U.K.
Georges ChalhoubInstitute of Systems, Molecular & Integrative Biology, University of Liverpool, LiverpoolL69 7ZX, U.K.
Peter J McCormickInstitute of Systems, Molecular & Integrative Biology, University of Liverpool, LiverpoolL69 7ZX, U.K.ORCID 0000-0002-2225-5181
Chris De GraafStructure Therapeutics, San Francisco, California94080, United States.ORCID 0000-0002-1226-2150
Ijen ChenNxera Pharma U.K., CambridgeCB21 6DG, U.K.ORCID 0000-0001-8865-3193
Giovanni BottegoniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino61029, Italy.ORCID 0000-0003-1251-583X

Funding

HORIZON EUROPE Marie Sklodowska-Curie Actions 956314
6 · The paper itself

Abstract

Understanding how allosteric modulators influence protein dynamics is essential for guiding drug design. This work analyses a total of 45 μs of classical molecular dynamics simulations for four class A G-protein-coupled receptors (GPCRs), namely the Complement C5a receptor (C5AR1), the Purinergic Receptor P2Y (P2RY1), and the Cannabinoid Receptors 1 and 2 (CNR1/CNR2). Protein dynamics is essential to detect the shallow extrahelical binding sites, such as the one found in P2RY1. Current methods for computing Allosteric Communication Networks (ACNs) produce complex outputs requiring expert interpretation. To address this, we focus on the shortest paths of information transfer between the orthosteric and G-protein binding sites in Class A GPCRs. Our retrospective analysis reveals state- and bias ligand-dependent residue interactions along these communication pathways. Furthermore, focusing on the predicted binding site of allosteric modulator EC21a at cannabinoid receptors, the ACN framework was used to prioritize two residues for mutational analysis that may contribute to allosteric communication.

Indexed as

Intracellular SpaceMolecular Dynamics SimulationReceptors, G-Protein-CoupledAllosteric RegulationAllosteric SiteBinding SitesHumansLigandsLigandsReceptors, G-Protein-Coupled

Identifiers

PMID42734521
PMCPMC13580027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.